Engaged Capital 13F, Q3 2024
Glenn Welling · quarter ending 30 September 2024 · filed 14 November 2024 · SEC CIK 1559771
Common stock only: shares the fund reported owning at the quarter end, valued as filed.
Largest positions, Q3 2024
Weights are against the whole filed book. Changes are in shares held, against the Q2 2024 filing.
| Company | Ticker | Value | % of book | vs Q2 2024 |
|---|---|---|---|---|
| EVOLENT HEALTH INC | EVH | $112.82M | 18.3% | -3% shares |
| V F CORP | VFC | $106.56M | 17.3% | unchanged |
| NCR VOYIX CORPORATION | VYX | $97.31M | 15.8% | +14% shares |
| NCR ATLEOS CORPORATION | NATL | $85.82M | 13.9% | +20% shares |
| PORTILLOS INC | PTLO | $82.37M | 13.4% | +122% shares |
| BRC INC | BRCC | $46.29M | 7.5% | +5% shares |
| PRA GROUP INC | PRAA | $38.09M | 6.2% | unchanged |
| BLACKLINE INC | BL | $33.62M | 5.5% | new |
| NEVRO CORP | $13.66M | 2.2% | +30% shares |
What changed since Q2 2024
Against the Q2 2024 filing, Engaged Capital opened 1 new position, added to 5, trimmed 1, left 2 unchanged and exited 4. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.
Other quarters
Source: SEC Form 13F-HR, accession 0000921895-24-002693, filed by Engaged Capital LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.